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A B ST R AC T  
 
Aim: To compare the parameters showing the platelet volume index in unstable angina pectoris 
(USAP), non-ST elevation myocardial infarction (non-STEMI) and ST elevation myocardial 
infarction (STEMI).  
Methods: The platelet volume indices of 94 USAP, 161 non-STEMI and 86 STEMI cases with a 
total of 341 patients (245 men, 96 women) were compared. The patients between March 2015 and 
October 2018 who admitted to Bolu Abant Izzet Baysal University Hospital with the diagnosis of 
acute coronary syndrome were compared using platelet distribution width (PDW), PDW to platelet 
ratio (PPR), mean platelet volume (MPV), MPV to platelet ratio (MPR).  
Results: No significant difference was found between the 3 groups in terms of PDW (p = 0.26), PPR 
(p = 0.87), MPV (p = 0.41) and MPR (p = 0.78) values. 
Conclusion: In our study, there was no statistically significant difference between the types of acute 
coronary syndrome and platelet volume indices. 
Keywords: Acute coronary syndromes, mean platelet volume, platelet distribution width, platelet 
volume indices. 
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Introduction 
Coronary artery disease is one of the most 
important health problems in both developed 
and developing countries [1]. Coronary artery 
disease may be in a wide range of stable angina 
pectoris and acute coronary syndrome 
including USAP (unstable angina pectoris), 
non-STEMI (non-ST elevation myocardial 
infarction) and STEMI (ST elevation 
myocardial infarction) and their prognosis and 
course vary widely [2]. Acute coronary 
syndromes are an important cause of 
hospitalization, mortality and morbidity 
worldwide [3]. Destruction and rupture of a 
stable plaque is also a stimulant for 
thrombogenesis and triggers a loss of function 
in the myocardial area of the coronary artery, 
whose flow is impaired in the acute coronary 
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syndrome, as well as the loss of cell death, 
ischemia-induced arrhythmias, and sudden 
cardiac death [4]. The importance and place of 
platelets and other hematological parameters in 
both acute and stable coronary artery diseases 
have been shown in many studies [5]. When 
the relationship between the activity and size 
of platelets is examined, it is known that 
thrombogenic activity of platelets increases in 
their size to the increase of thrombogenic 
granules on the platelets and of the receptors 
on the surface [6]. PDW (platelet distribution 
width), PPR (PDW to platelet ratio), MPV 
(mean platelet volume), MPR (MPV to platelet 
ratio) values are parameters that show the size 
and activity of platelets [7,8,9]. These 
parameters, which are indirect indicators of 
platelet activation, have been studied in a wide 
variety of disease groups such as cancer, 
inflammatory diseases, rheumatologic 
diseases, hypertension, diabetes, dyslipidemia 
and obesity and the effects of them on the 
diagnosis, follow-up and prognosis of diseases 
were shown in the literature [10,11]. 
The aim of our study is to compare the platelet 
volume indices using PDW, PPR, MPV and 
MPR values in patients with acute coronary 
syndrome. 
 
Methods  
Between March 2015 and October 2018, a total 
of 341 patients (245 men, 96 women) with 94 
USAP, 116 non-STEMI and 86 STEMI who 
admitted to our hospital with the diagnosis of 
acute coronary syndrome were evaluated with 
coronary angiography results and hemogram 
parameters. 
Age, gender, drugs, smoking, hypertension, 
hyperlipidemia, diabetes and family history, 
height and weight data were recorded in all 
patients. Hypertension diagnosed in patients 
with systolic blood pressure > 140 mmHg 
and/or diastolic blood pressure > 90 mmHg or 
presently receiving anti-hypertensive 
treatment. Diabetes was defined as fasting 
blood glucose > 126 mg/dl or related drug 
intake. Hyperlipidemia was defined as total 
cholesterol > 200 mg/dl or triglyceride > 150 
mg/dl. 
Patients with acute chest pain and persistent 
(>20 min) ST-segment elevation were defined 
as STEMI. Patients with acute chest pain but 
no persistent ST-segment elevation (transient 
ST-segment elevation, persistent or transient 
ST-segment depression, T-wave inversion, flat 
T waves or pseudo-normalization of T waves 
or normal ECG) and a clue for myocardial 
necrosis defined as NSTEMI. Unstable angina 
was defined as myocardial ischemia at rest or 
minimal exertion in the absence of 
cardiomyocyte necrosis [12]. 
The criteria for ST segment elevation were 
taken as follows: 1) At least 1 mm ST segment 
elevation in at least two successive leads, 2) 
2.5 mm in men under 40 years of age, 2 mm in 
men over 40 years and 1.5 mm ST segment 
elevation in women in V2 and V3, 3) 0.5 mm 
ST segment elevation in V7-V9 (at least 2 
consecutive lines), 4) 0.5 mm ST segment 
elevation in V3R and V4R (1 mm in men under 
40). 
Coronary angiography was performed by 
femoral or radial route using Seldinger 
technique. Coronary angiograms were 
evaluated by at least two cardiologists who 
were experienced and blinded to the 
independent study. 
Venous blood samples were taken within the 
first 6 h of admission to hospital. Glucose, 
creatinine and lipid profiles were determined 
by standard methods. MPV and PDW values 
were studied in tri-potassium EDTA 
(Ethylenediaminetetraacetic acid) tubes. The 
PPR was calculated by dividing the PDW 
                                                        Mansiroglu et al.  Exp Biomed Res 2019; 2(3):85-92 
   
 
87 
 
value by the number of platelets and MPR was 
calculated by dividing the MPV value by the 
number of platelets. Patients who were 
diagnosed with acute coronary syndrome in the 
last 6 months, patients with coronary bypass 
history, decompensated heart failure, atrial 
fibrillation, cardiomyopathy or congenital 
heart disease, inflammatory disease, renal or 
hepatic failure, cancer, septicemia, pregnancy 
and thrombocytopenia were excluded from the 
study. The study was approved by the Local 
Ethics Committee of Bolu Abant Izzet Baysal 
University Hospital, Turkey. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Statistical analysis 
Analyses were carried out using SPSS 16.0 
Statistical Package Program for Windows 
(SPSS Inc, Chicago, Illinois, USA).  
Quantitative variables are expressed as mean± 
standard deviation (SD), and qualitative 
variables as numbers and percentages. 
Differences between independent groups was 
assessed by Student t-test for normally 
distributed quantitative variables and Mann-
Whitney’s U-test for variables without normal 
distribution and Chi-square test for qualitative 
variables. All results were considered 
statistically significant at the level of p≤ 0.05. 
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Results 
Baseline patient demographics, including age, 
sex and clinical risk factors, were compared 
between the groups. While demographic 
factors of age, gender, smoking, family history 
and presence of diabetes were not statistically 
significant among the 3 groups, body mass 
index was the lowest in the USAP group and 
the highest in the STEMI group (p=0.004). 
The presence of hypertension was the lowest in 
the STEMI group and the highest in non-
STEMI group (p=0.002). Previous 
medications were also comparable between the 
three groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
While the use of acetylsalicylate, clopidogrel, 
statin, calcium channel blocker and ACE 
(angiotensin-converting enzyme) inhibitor 
were not significantly different between 
groups; ARB (angiotensin receptor blocker) 
and beta-blockers were found to be the lowest 
in the STEMI group and the highest in the non-
STEMI group (p=0.008 and p=0.001) (Table 
1). 
When blood parameters of patients were 
examined, no significant difference was found 
between creatinine, LDL-cholesterol, HDL-
cholesterol,    triglyceride,   total   cholesterol,  
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hematocrit, hemoglobin and platelet counts 
while plasma glucose levels were highest in the 
USAP group; lowest in the STEMI group (p = 
0.02). There was no statistically significant 
difference between the three groups in terms of 
platelet function tests which formed the aim of 
our study, PDW (p=0.26), PPR (p=0.87), 
MPV (p=0.41) and MPR (p=0.78) (Table 2). 
 
Discussion 
In this study, platelet volume indices PDW, 
PPR, MPV and MPR values were not 
significantly different among the patients with 
acute coronary syndrome. Atherosclerosis 
causing coronary artery disease (CAD) is a 
chronic process. After a silent period, a stable 
or unstable clinical picture may occur. Acute 
coronary syndrome (ACS) is a wide spectrum 
of exacerbation periods, including USAP, non-
STEMI and STEMI. Inflammation and platelet 
activation are the cornerstones of both 
atherosclerosis and acute coronary syndromes. 
Platelets are important triggers in the 
atherothrombotic process with their direct 
inflammatory mediators as well as their direct 
effects on the inflammatory pathway [13]. 
Activated platelets initiate the free arachidonic 
acid pathway; prostaglandins produced in the 
process starting with this pathway, especially 
thromboxane A2 is the most potent 
vasoconstrictor and platelet activating 
substrate [14]. Large platelets are more 
enzymatic and metabolically more active due 
to the higher content of pro-aggregate 
mediators and more surface proteins (p-
selectin, Glycoprotein -IIb/IIIa) [15,16]. The 
two most well-known parameters showing the 
platelet size are MPV and PDW, and these two 
values have been used in the literature for 
many times [7,19-30]. PDW is more specific in 
demonstrating activation; unlike MPV, it does 
not increase with simple platelet swelling [17]. 
An example might be the correlation between 
increased PDW and MPV with shortened 
bleeding time [18]. In addition to studying the 
prognostic significance of these markers in a 
wide variety of patient groups, patients with 
acute coronary syndrome were compared with 
stable coronary artery disease and non-cardiac 
patients [2]. The comparison between the 3 
groups was not found in the existing literature 
and such a comparison of these values 
especially in the Turkish population constitutes 
a first study. 
In the literature, platelet volume, PDW and P-
LCR (platelet larger cell ratio) values were 
significantly higher in USAP and acute MI 
patients than in stable CAD and control group 
[19]. While these values were used for 
prognosis as well, PDW value was determined 
as a predictor in the patients who had 
saphenous vein occlusion [20]. In another 
study, STEMI patients were compared with the 
control group and as a result, PDW and MPV 
values were found to be significantly high and 
were associated with STEMI severity [7]. 
Following the literature there are studies in 
parallel with the results of our study, in which 
no significant relationship was observed. For 
example, in 1300 patients who underwent 
percutaneous coronary intervention, in the 
study that investigated the relationship 
between peri-procedural MI and PDW, patients 
were examined in 3 groups according to PDW 
value and it was concluded that the increase in 
PDW did not increase the risk of peri-
procedural MI [21]. In another study, 2330 
patients who underwent coronary angiography 
were divided into 3 groups. There was no 
significant relationship between CAD grade 
and carotid IMT (intima-media thickness), 
MPV and PDW [18]. Similar findings were 
also found in the studies of Tavil et al and 
Halbmayer et al [22-24]. In the literature, the 
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relation of MPR and PPR ratios of platelet 
volume indices with prognosis in various 
cancer types have been studied [25]. The 
correlation with the severity of coronary artery 
disease in patients with non-STEMI [26] and 
the relationship with disease severity in 
pediatric intensive care unit (PICU) [27] have 
been studied previously. However, in our 
study, these values were compared in 3 types 
of acute coronary syndromes. 
In our study, we examined patients in 3 groups 
under the title of acute coronary syndrome and 
compared them with platelet volume index 
parameters, however we did not find any 
significant difference. Although these 3 
clinical manifestations may present with 
different clinical and severity, the underlying 
pathophysiological events may overlap in a 
common pathway. In addition, circulating 
platelets have a life span of about 10 days [28]. 
Since, the blood samples were taken from the 
patients who were in the first 6 h of 
hospitalization, our calculation included the 
90% of the platelets which are in fact 
independent of the acute coronary syndrome 
but already in the circulation at the time of 
measurement. Thus, this may explain the 
statistical insignificance between the groups. 
Although previous studies have shown that 
these values change with blood uptake in 
supine or sitting position [29], patients’ 
positions during blood collection could not be 
standardized due to the retrospective design of 
our study. This deficiency may have affected 
statistical values. The fact that the study was 
conducted only in the Turkish population may 
prevent us to generalize the values that have 
been shown to be influenced by ethnic factors 
[30]. Single-center and the limited number of 
patients might be considered as the other 
limitations in our study. 
 
Informed Consent: Informed consent was 
obtained from all individual participants 
included in the study.  
All procedures performed in studies involving  
human  participants  were  in  accordance  with  
the ethical  standards  of  the  Institutional  
Research Ethics Committee and with the 1964  
Helsinki Declaration and its later amendments  
or comparable ethical standards.  
 
Conflicts of interest: There are no conflicts of 
interest. 
Funding sources: This research did not 
receive any specific grant from funding 
agencies in the public, commercial, or not-for-
profit sectors. 
 
References 
[1] Bekler A, Gazi E, Yilmaz M, Temiz A, 
Altun B, Barutcu A, et al. Could elevated 
platelet-lymphocyte ratio predict left 
ventricular systolic dysfunction in patients 
with non-ST elevated acute coronary 
syndrome? Anatol J Cardiol. 2015; 
15(5):385-90. 
[2] Thaulow E, Erikssen J, Sandvik L, 
Stormorken H and Cohn PF. Blood platelet 
count and function are related to total and 
cardiovascular death in apparently healthy 
men. Circulation. 1991; 84(2):613-17. 
[3] Falk E, Nakano M, Bentzon JF, Finn AV 
and Virmani R. Update on acute coronary 
syndromes: the pathologists' view. Eur 
Heart J. 2013; 34(10):719-28. 
[4] Amsterdam EA, Wenger NK, Brindis RG, 
Casey DE, Jr., Ganiats TG,  et al. 2014 
AHA/ACC Guideline for the Management 
of Patients with Non-ST-Elevation Acute 
Coronary Syndromes: a report of the 
American College of Cardiology/American 
Heart Association Task Force on Practice 
                                                        Mansiroglu et al.  Exp Biomed Res 2019; 2(3):85-92 
   
 
91 
 
Guidelines. J Am Coll Cardiol. 2014; 
64(24):e139-e228. 
[5] Oylumlu M, Yıldız A, Oylumlu M, Yüksel 
M, Polat N, Bilik MZ, et al.Platelet-to-
lymphocyte ratio is a predictor of in-
hospital mortality patients with acute 
coronary syndrome. Anatol J Cardiol. 2015; 
15(4):277. 
[6] Cesari F, Marcucci R, Gori AM, Caporale 
R, Fanelli A, Casola G, et al.  Reticulated 
platelets predict cardiovascular death in 
acute coronary syndrome patients. Thromb 
Haemost. 2013; 109(05):846-53. 
[7] Coban E. Comment on “A study of 
association between platelet volume indices 
and ST elevation myocardial infarction”. Int 
J Cardiol Heart Vasc. 2018; 21:56. 
[8] Herve P, Humbert M, Sitbon O, Parent F, 
Nunes H, Legal C, et al.Pathobiology of 
pulmonary hypertension. The role of 
platelets and thrombosis. Clin Chest Med. 
2001; 22(3):451-58. 
[9] Martin J, Trowbridge E, Salmon G and 
Plumb J. The biological significance of 
platelet volume: its relationship to bleeding 
time, platelet thromboxane B2 production 
and megakaryocyte nuclear DNA 
concentration. Thromb Res. 1983; 
32(5):443-60. 
[10] Gasparyan AY, Ayvazyan L, Mikhailidis 
DP and Kitas GD. Mean platelet volume: a 
link between thrombosis and inflammation? 
Curr Pharm Des. 2011; 17(1):47-58. 
[11] Franco AT, Corken A and Ware J. Platelets 
at the interface of thrombosis, 
inflammation, and cancer. Blood. 2015; 
126(5):582-88. 
[12] Roffi M, Patrono C, Collet JP, Mueller C, 
Valgimigli M, Andreotti F, et al. 2015 ESC 
Guidelines for the management of acute 
coronary syndromes in patients presenting 
without persistent ST-segment elevation: 
Task Force for the Management of Acute 
Coronary Syndromes in Patients Presenting 
without Persistent ST-Segment Elevation of 
the European Society of Cardiology (ESC). 
Eur Heart J. 2016; 37(3):267-315. 
[13] Davi G and Patrono C. Platelet activation 
and atherothrombosis. N Engl J Med. 2007; 
357(24):2482-94. 
[14] Pal R, Bagarhatta R, Gulati S, Rathore M 
and Sharma N. Mean platelet volume in 
patients with acute coronary syndromes: a 
supportive diagnostic predictor. Journal of 
clinical and diagnostic research: JCDR. 
2014; 8(8):MC01. 
[15] Verdoia M, Schaffer A, Barbieri L, 
Suryapranata H and De Luca G. Bivalirudin 
as compared to unfractionated heparin in 
patients undergoing percutaneous coronary 
revascularization: A meta-analysis of 22 
randomized trials. Thromb Res. 2015; 
135(5):902-15. 
[16] De Luca G, Dudek D, Sardella G, Marino P, 
Chevalier B and Zijlstra F. Adjunctive 
manual thrombectomy improves 
myocardial perfusion and mortality in 
patients undergoing primary percutaneous 
coronary intervention for ST-elevation 
myocardial infarction: a meta-analysis of 
randomized trials. Eur Heart J. 2008; 
29(24):3002-3010. 
[17] Khandekar MM, Khurana AS, Deshmukh 
SD, Kakrani AL, Katdare AD and Inamdar 
AK. Platelet volume indices in patients with 
coronary artery disease and acute 
myocardial infarction: an Indian scenario. J 
Clin Pathol. 2006; 59(2):146-49. 
[18] Varasteh-Ravan HR, Ali-Hassan-Sayegh S, 
Shokraneh S, Mozayan MR and Karimi-
Bondarabadi AA. Relationship of 
admission mean platelet volume, platelet 
distribution width and white blood cells 
with ST resolution in patients with acute ST 
                                                        Mansiroglu et al.  Exp Biomed Res 2019; 2(3):85-92 
   
 
92 
 
segment elevation myocardial infarction 
treated with streptokinase without history of 
previous cardiovascular surgery. Perspect 
Clin Res. 2013; 4(2):125-29. 
[19] Maden O, Kacmaz F, Selcuk MT, Selcuk H, 
Metin F, Tufekcioglu O, et al. Relationship 
of admission haematological indices with 
infarct-related artery patency in patients 
with acute ST-segment elevation 
myocardial infarction treated with primary 
angioplasty. Coron Artery Dis. 2007; 
18(8):639-44. 
[20] Ege MR, Guray U, Guray Y, Acikgoz S and 
Demirkan B. Platelet distribution width and 
saphenous vein disease in patients after 
CABG. Association with graft occlusion. 
Herz. 2013; 38(2):197-201 
[21] Verdoia M, Barbieri L, Schaffer A, Cassetti 
E, Di Giovine G, Bellomo G, et al. Platelet 
distribution width and the risk of 
periprocedural myocardial infarction in 
patients undergoing percutaneous coronary 
intervention. J Thromb Thrombolysis. 
2014; 37(3):345-52. 
[22] De Luca G, Venegoni L, Iorio S, Secco GG, 
Cassetti E, Verdoia M,et al. . Platelet 
distribution width and the extent of 
coronary artery disease: results from a large 
prospective study. Platelets. 2010; 
21(7):508-14. 
[23] Tavil Y, Sen N, Yazici HU, Hizal F, Abaci 
A and Cengel A. Mean platelet volume in 
patients with metabolic syndrome and its 
relationship with coronary artery disease. 
Thromb Res. 2007; 120(2):245-50. 
[24] Halbmayer WM, Haushofer A, Radek J, 
Schon R, Deutsch M and Fischer M. 
Platelet size, fibrinogen and lipoprotein(a) 
in coronary heart disease. Coron Artery Dis. 
1995; 6(5):397-402. 
[25] Takeuchi H, Abe M, Takumi Y, Hashimoto 
T, Kobayashi R, Osoegawa A, et al.The 
prognostic impact of the platelet 
distribution width-to-platelet count ratio in 
patients with breast cancer. PloS one. 2017; 
12(12):e0189166. 
[26] Taskesen T, Sekhon H, Wroblewski I, 
Goldfarb M, Ahmad MB, Nguyen QT, et al. 
Usefulness of Mean Platelet Volume to 
Predict Significant Coronary Artery 
Disease in Patients With Non-ST-Elevation 
Acute Coronary Syndromes. Am J Cardiol. 
2017; 119(2):192-96. 
[27] Purbiya P, Golwala ZM, Manchanda A, 
Sreenivas V and Puliyel JM. Platelet 
Distribution Width to Platelet Count Ratio 
as an Index of Severity of Illness. Indian J 
Pediatr. 2018; 85(1):10-14. 
[28] Chu H, Chen WL, Huang CC, Chang HY, 
Kuo HY, Gau CM, et al. Diagnostic 
performance of mean platelet volume for 
patients with acute coronary syndrome 
visiting an emergency department with 
acute chest pain: the Chinese scenario. 
Emerg Med J. 2011; 28(7):569-74. 
[29] Glud T, Schmidt EB, Kristensen SD and 
Arnfred T. Platelet number and volume 
during myocardial infarction in relation to 
infarct size. Acta Med Scan. 1986; 
220(5):401-405. 
[30] Abudesimu A, Liu F, Siti D, Adi D, Fu Z, 
Ma X, et al. An assessment of platelet 
parameters in different ethnic groups with 
hypertension subtypes and associated risk 
factors in Xinjiang, China. Clin Exp 
Hypertens. 2018; 40(6):574-81. 
 
